Peter Willeit
Impact in
- Aging top 0.2%
-
- Blood Pressure and Hypertension Studies
Papers in
-
- Cardiovascular Health and Disease Prevention 17
- Blood Pressure and Hypertension Studies 13
- Physiology 28
- Telomeres, Telomerase, and Senescence 14
- Co-authors
- Stefan Julia Kiechl (54 shared papers)Johann Willeit (41 shared papers)Manuel Mayr (23 shared papers)Agnes Mayr (8 shared papers)Anna Zampetaki (12 shared papers)Siegfried Weger (8 shared papers)Ignat A. Drozdov (5 shared papers)Florian Kronenberg (13 shared papers)
- Journals
- The Lancet (23 papers)European Journal of Preventive Cardiology (12 papers)Journal of the American Heart Association (9 papers)European Heart Journal (9 papers)Atherosclerosis (8 papers)
- Partner nations
- United KingdomAustriaUnited States
In The Last Decade
Peter Willeit
244 papers receiving 41.8k citations
Peter Willeit's Hit Papers
Peers
Comparison fields: 5 of 209
- Aging 648
- Cardiology and Cardiovascular Medicine 5.8k
- Physiology 5.7k
- Cancer Research 2.7k
- Endocrinology, Diabetes and Metabolism 3.0k
Countries citing papers authored by Peter Willeit
This map shows the geographic impact of Peter Willeit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Willeit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Willeit more than expected).
Fields of papers citing papers by Peter Willeit
This network shows the impact of papers produced by Peter Willeit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Willeit. The network helps show where Peter Willeit may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Willeit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 253 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults Hit paper breakdown → | 2017 | 5897 |
| 2 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 2923 |
| 3 | Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants Hit paper breakdown → | 2021 | 2506 |
| 4 | Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents Hit paper breakdown → | 2016 | 2103 |
| 5 | Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants Hit paper breakdown → | 2016 | 1807 |
| 6 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1647 |
| 7 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1622 |
| 8 | Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes Hit paper breakdown → | 2010 | 1256 |
| 9 | Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults Hit paper breakdown → | 2024 | 1250 |
| 10 | SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe Hit paper breakdown → | 2021 | 1121 |
| 11 | Cardioprotection and lifespan extension by the natural polyamine spermidine Hit paper breakdown → | 2016 | 952 |
| 12 | World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions Hit paper breakdown → | 2019 | 836 |
| 13 | Association of Cardiometabolic Multimorbidity With Mortality Hit paper breakdown → | 2015 | 820 |
| 14 | Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis Hit paper breakdown → | 2014 | 722 |
| 15 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 654 |
| 16 | Rising rural body-mass index is the main driver of the global obesity epidemic in adults Hit paper breakdown → | 2019 | 549 |
| 17 | Association ofLPAVariants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies Hit paper breakdown → | 2018 | 528 |
| 18 | Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis Hit paper breakdown → | 2018 | 480 |
| 19 | Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants Hit paper breakdown → | 2024 | 478 |
| 20 | 2014 | 471 |
About Peter Willeit
Peter Willeit is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Cancer Research, Infectious Diseases and Epidemiology, having authored 253 papers that have together received 43.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (21 papers), SARS-CoV-2 and COVID-19 Research (18 papers), Cardiovascular Health and Disease Prevention (17 papers), Telomeres, Telomerase, and Senescence (14 papers), Blood Pressure and Hypertension Studies (13 papers), MicroRNA in disease regulation (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and COVID-19 Clinical Research Studies (9 papers). The work is most often cited by research in Aging (648 citations), Cardiology and Cardiovascular Medicine (5.8k citations), Physiology (5.7k citations), Cancer Research (2.7k citations) and Endocrinology, Diabetes and Metabolism (3.0k citations). Peter Willeit has collaborated with scholars based in United Kingdom, Austria and United States. Frequent co-authors include Stefan Julia Kiechl, Johann Willeit, Manuel Mayr, Agnes Mayr, Anna Zampetaki, Siegfried Weger, Ignat A. Drozdov, Florian Kronenberg, Friedrich Oberhollenzer and Marianna Prokopi. Their work appears in journals such as The Lancet, European Journal of Preventive Cardiology, Journal of the American Heart Association, European Heart Journal and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.